Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2021-03-17 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
109年度應收帳款周轉率
Regulatory Filings Classification · 90% confidence The document is very short (281 characters) and contains a brief financial metric table related to accounts receivable turnover and average collection days for two fiscal years (108 and 109). There is no indication of a full report, detailed financial statements, or comprehensive analysis. It appears to be a snippet or a brief disclosure rather than a full financial report or announcement. Given the brevity and nature of the content, it does not fit into detailed report categories like Annual Report (10-K) or Interim Report (IR). It also does not match categories like Earnings Release or Management Reports. The document is more likely a Regulatory Filing (RNS) as a general disclosure or compliance update without substantive financial data or detailed reporting.
2021-03-17 Chinese
109年度存貨週轉率
Fund Information / Factsheet Classification · 90% confidence The document is very short (279 characters) and contains a brief table with inventory turnover rates and average sales days for two fiscal years (108 and 109). There is no detailed financial data, narrative, or comprehensive report content. It appears to be a simple data disclosure or a brief fact sheet rather than a full report or announcement. Given the brevity and nature of the content, it does not fit into detailed report categories like Annual Report (10-K) or Interim Report (IR). It also does not match categories like Earnings Release or Management Reports. The document is more aligned with a Fund Information / Factsheet (FS) due to its concise summary of key financial metrics. Confidence is high due to clear content type and length.
2021-03-17 Chinese
本公司經證交所同意自110年3月17日起恢復交易
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (1720 生達) stating that the stock exchange has agreed to resume trading of the company's shares starting from a specific date (March 17, 110 in the ROC calendar). It mentions the suspension of trading due to pending material information and the subsequent lifting of the suspension. The document is brief (544 characters) and serves as a regulatory announcement about trading status rather than a financial report or detailed disclosure. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-03-16 Chinese
公告本公司董事會決議召開一一○年股東常會事宜
AGM Information Classification · 95% confidence The document is a formal announcement from the company 1720 生達 regarding the board of directors' resolution to convene the Annual General Meeting (AGM) for the year 110 (Taiwan calendar year). It details the date, location, agenda items including reports, approvals, discussions, elections, and other procedural matters related to the AGM. The document does not contain the actual AGM materials or presentations but rather the notice and details about the AGM meeting itself. The document length is short (1423 characters) and it is clearly an announcement of the AGM meeting, not the AGM materials or presentations. Therefore, it fits the category of AGM Information (AGM-R).
2021-03-16 Chinese
本公司董事會決議通過分割合成部門讓與生泰合成 工業股份有限公司及其分割計畫書案
Merger & Acquisition Classification · 100% confidence The document is a detailed announcement regarding a corporate restructuring transaction involving a division spin-off and transfer to another company, including specifics about the transaction type (division split), involved parties, valuation, share exchange ratio, legal and accounting opinions, and planned dates. It includes detailed information about the merger/acquisition activity, such as the transfer of assets and liabilities, share issuance as consideration, and related corporate governance matters. The presence of terms like '分割' (split), '併購' (merger/acquisition), valuation, share exchange, and detailed transaction terms indicates this is related to M&A activity. The document is not a full annual or interim report, nor is it a simple announcement or certification. It is a comprehensive disclosure of a merger/acquisition transaction. Therefore, the appropriate classification is Merger & Acquisition (MA).
2021-03-16 Chinese
新聞稿-生達化學製藥股份有限公司新聞稿
Capital/Financing Update Classification · 95% confidence The document is a news release from the company 生達化學製藥股份有限公司 (stock code 1720) announcing a business transaction involving the division and transfer of its raw material drug synthesis department to another company, 生泰公司 (stock code 1777). It details the board resolutions, valuation, share issuance as consideration, and strategic rationale behind the transaction. The document is short (1497 characters) and primarily serves as an announcement of a corporate action related to business restructuring and capital issuance. It does not contain financial statements, detailed financial performance data, or comprehensive management discussion. It is not a full annual or interim report, nor a detailed investor presentation or earnings release. The content fits best under Capital/Financing Update (CAP) because it involves issuance of new shares as consideration for the business division transfer and changes in shareholding structure. Therefore, the classification is CAP with high confidence.
2021-03-16 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.